AVAGE (tazarotene)
PSORIASIS·+5
Allergan
Indication
Facial hyperpigmentation
Facial hyperpigmentation is a common dermatologic condition characterized by the localized or patchy darkening of the skin on the face due to excessive melanin synthesis and deposition within the epidermis or dermis. Read more about Facial hyperpigmentation
10 drugs 8 manufacturers
Drugs that treat it
Common Facial hyperpigmentation therapies.
OBAGI SYSTEM
TAZAROTENE
ACNE PRODUCTS·PSORIASIS·+5
TARO PHARM USA
TAZAROTENE
ACNE PRODUCTS·PSORIASIS·+5
PACIFIC/GREENST
TAZAROTENE
PSORIASIS·+5
G & W LABS.
TAZAROTENE
ACNE PRODUCTS·PSORIASIS·+5
Cosette Pharmaceuticals
OBAGI SYSTEM
OBAGI SYSTEM
TAZAROTENE
ACNE PRODUCTS·PSORIASIS·+5
MIDLOTHIAN LABO
Filter & compare in the drug finder →Opens the drug finder with Facial hyperpigmentation preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFacial hyperpigmentation is a common dermatologic condition characterized by the localized or patchy darkening of the skin on the face due to excessive melanin synthesis and deposition within the epidermis or dermis.
It predominantly affects the integumentary system of adults—most frequently individuals with darker skin phototypes and women undergoing hormonal fluctuations.
Pathophysiologically driven by melanocyte hyperactivity triggered by ultraviolet radiation, visible light, cutaneous inflammation, or hormonal influences, it manifests clinically as tan, brown, or gray-brown macules and patches across prominent facial regions such as the forehead, cheeks, and perioral areas.
Common clinical presentations encompassed by this term include melasma, solar lentigines, and post-inflammatory hyperpigmentation.
- nih.gov
Facial hyperpigmentation is a common dermatologic condition characterized by the localized or patchy darkening of the skin on the face due to excessive melanin synthesis and deposition within the epidermis or dermis It predominantly affects the integumentary system of adults—most frequently individuals with darker skin phototypes and women undergoing hormonal fluctuations
- merckmanuals.com
Facial hyperpigmentation is a common dermatologic condition characterized by the localized or patchy darkening of the skin on the face due to excessive melanin synthesis and deposition within the epidermis or dermis Common clinical presentations encompassed by this term include melasma, solar lentigines, and post-inflammatory hyperpigmentation
- nih.gov
It predominantly affects the integumentary system of adults—most frequently individuals with darker skin phototypes and women undergoing hormonal fluctuations Pathophysiologically driven by melanocyte hyperactivity triggered by ultraviolet radiation, visible light, cutaneous inflammation, or hormonal influences, it manifests clinically as tan, brown, or gray-brown macules and patches across prominent facial regions such as the forehead, cheeks, and perioral areas
- arizonaderm.com
Pathophysiologically driven by melanocyte hyperactivity triggered by ultraviolet radiation, visible light, cutaneous inflammation, or hormonal influences, it manifests clinically as tan, brown, or gray-brown macules and patches across prominent facial regions such as the forehead, cheeks, and perioral areas
- asds.net
Pathophysiologically driven by melanocyte hyperactivity triggered by ultraviolet radiation, visible light, cutaneous inflammation, or hormonal influences, it manifests clinically as tan, brown, or gray-brown macules and patches across prominent facial regions such as the forehead, cheeks, and perioral areas
- nih.gov
Common clinical presentations encompassed by this term include melasma, solar lentigines, and post-inflammatory hyperpigmentation
- aafp.org
Common clinical presentations encompassed by this term include melasma, solar lentigines, and post-inflammatory hyperpigmentation
Personalize your experience
Follow Facial hyperpigmentation and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.